Xun Zhu
Director/Board Member at SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD.
Net worth: 766 569 $ as of 31/05/2024
Profile
Xun Zhu is currently serving as an Independent Non-Executive Director at Sihuan Pharmaceutical Holdings Group Ltd., an Independent Director at Shenzhen Chipscreen Biosciences Co., Ltd., and an Independent Non-Executive Director at Lansen Pharmaceutical Holdings Ltd.
He is also a Non-Executive Director at Cathay International Pharmaceutical Ltd., Hightide Therapeutics, Inc., and Medtide, Inc. Additionally, Dr. Zhu holds the position of Deputy Director at China Medicinal Biotech Association and is a Member-Life Science Division at the National Natural Science Foundation of China.
In the past, Dr. Zhu worked as an Independent Non-Executive Director at Apollomics, Inc. (United States) and as a Professor at Jilin University from 1994 to 2018.
Dr. Zhu obtained his doctorate degree from Norman Bethune Medical University in 1989.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/04/2024 | 856,605 ( 0.17% ) | 559 509 $ | 31/05/2024 | |
| 30/06/2023 | 3,000,000 ( 0.03% ) | 207 060 $ | 31/05/2024 |
Xun Zhu active positions
| Companies | Position | Start |
|---|---|---|
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. | Director/Board Member | 20/02/2014 |
| SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD. | Director/Board Member | 24/03/2018 |
| LANSEN PHARMACEUTICAL HOLDINGS LIMITED | Director/Board Member | 23/09/2022 |
| HIGHTIDE THERAPEUTICS, INC. | Director/Board Member | 30/11/2020 |
| Cathay International Pharmaceutical Ltd. | Director/Board Member | 01/08/2011 |
| China Medicinal Biotech Association | Corporate Officer/Principal | - |
| Norman Bethune Medical University | Corporate Officer/Principal | 01/01/1995 |
| National Natural Science Foundation of China | Corporate Officer/Principal | - |
Taide Pharmaceutical (Zhejiang) Co., Ltd.
 Taide Pharmaceutical (Zhejiang) Co., Ltd. BiotechnologyHealth Technology Medtide, Inc. is a peptide focused contract research, development and manufacturing organization. It services include contract research organization services, namely peptide new chemical entity discovery synthesis, contract development and manufacturing organization services, namely peptide chemistry, manufacturing and controls development, and contract manufacturing organization services, namely peptide NCE and generic drug commercial manufacturing. The company was founded by Li Xiang and Xu Qi on June 11, 2020 and is headquartered in Shaoxing, China. | Director/Board Member | 01/05/2024 |
Former positions of Xun Zhu
| Companies | Position | End |
|---|---|---|
| ░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Xun Zhu
| Norman Bethune Medical University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. | Health Technology |
| SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD. | Health Technology |
| LANSEN PHARMACEUTICAL HOLDINGS LIMITED | Health Technology |
| HIGHTIDE THERAPEUTICS, INC. | Health Technology |
| Private companies | 5 |
|---|---|
| Cathay International Pharmaceutical Ltd. | |
| China Medicinal Biotech Association | |
Apollomics, Inc. (United States)
 Apollomics, Inc. (United States) BiotechnologyHealth Technology Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA. | Health Technology |
| National Natural Science Foundation of China | Government |
Taide Pharmaceutical (Zhejiang) Co., Ltd.
Taide Pharmaceutical (Zhejiang) Co., Ltd. BiotechnologyHealth Technology Medtide, Inc. is a peptide focused contract research, development and manufacturing organization. It services include contract research organization services, namely peptide new chemical entity discovery synthesis, contract development and manufacturing organization services, namely peptide chemistry, manufacturing and controls development, and contract manufacturing organization services, namely peptide NCE and generic drug commercial manufacturing. The company was founded by Li Xiang and Xu Qi on June 11, 2020 and is headquartered in Shaoxing, China. | Health Technology |
- Stock Market
- Insiders
- Xun Zhu
